Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

Abstract

Prostate-specific antigen (PSA)-based prostate cancer screening in combination with shared decision-making (SDM) is recommended. Current data regarding risk from population-based cohorts provide a basis for longer screening intervals and tailored screening, and the use of available online risk calculators is encouraged.